Trending Sources

UC San Diego Nobel Laureate Roger Tsien Dies at 64

Xconomy

He was 64, and had been a professor at the UC San Diego School of Medicine for 27 years. Various Fluorescing Proteins.

EY Names 6 Startup Leaders as San Diego Entrepreneurs of the Year

Xconomy

Award winners from San Diego and other regions are now eligible for consideration for the national Entrepreneur Of The Year 2016 program.

San Diego’s KnuEdge, Stealthy Since 2005, Unveils Neural Tech

Xconomy

The company now has about 100 employees at its San Diego headquarters, and in offices in Austin, TX, and Redwood City, CA.

Todd Hylton Adds Neural Tech Expertise to UCSD Robotics Institute

Xconomy

UC San Diego has named Todd Hylton, a veteran tech industry manager and expert in neural-based processing technology, as executive director of its new Contextual Robotics Institute. Hylton’s appointment comes less than two months after UC San Diego named Henrik Christensen as director of the robotics institute. SAIC).

UCSD 16

Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches

Xconomy

But immunotherapy is also creating new challenges and exacerbating old ones for doctors, patients, and researchers.

Study 32

Avalon Leads $18M in Early Funding for Cancer Immunotherapy Startup

Xconomy

Fortis also has recruited a prominent prostate cancer researcher, Eric Small of UCSF, to the company’s scientific advisory board. Bregua Corp.,

Qualcomm and AT&T Partner to Use Wireless Network for Drone Flights

Xconomy

In today’s announcement, Qualcomm Technologies and AT&T say they intend to operate drones on commercial 4G LTE networks.

CTO 32

14 for ’17: Key Clinical Data To Watch For Next Year (Part 2)

Xconomy

We continue our look ahead to some of the clinical data due in 2017 that could shape healthcare practice and sway investor sentiment for years to come. Part one of our preview is here , with looks at key studies in lung cancer, Alzheimer’s disease, asthma, and more. Editor’s note: Ben Fidler and Frank Vinluan contributed to this report.]

Qualcomm Making Inroads with Wireless EV Charging Technology

Xconomy

As the global market for mobile phones has matured, Qualcomm has been seeking new opportunities in the wireless technology business. and other nations.

San Diego Sees Strong Cybersecurity Growth As Firms Seek Talent

Xconomy

San Diego’s cybersecurity workforce has grown by nearly 15 percent over the past two years, according to a study released today by the Cyber Center of Excellence, a nonprofit industry group created to boost cybersecurity jobs and technologies in the region. The center also asked the San Diego Regional Economic Development Corp.

Sluggish Year for IPOs, But Signs Abound of Post-Election Surge

Xconomy

The institutional research firm is predicting a surge of IPOs in the weeks and months to come.

BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders

Xconomy

Today they’re finally shedding a little light on what they’ve been up to. Today, BlackThorn is making its first formal announcement. It’s similar here.

Study 29

Precision Medicine In Trump Era? California Presses Own Modest Program

Xconomy

Bush healthcare Institute of Computational Health Sciences Life Sciences Obama PMI Precision Medicine Stem Cell Research UCSF University of Californi

Press 22

All In One Place: A New Immuno-Oncology Trial Resource

Xconomy

The infections were turbo-charging the immune system. But those data are impossible to find all in one place. As reporters, we find that frustrating.

Cybersecurity Startup MedCrypt Gets $750K to Defend Health Devices

Xconomy

Safeguard Scientifics also is an investor in Sotera Wireless, the San Diego-based maker of wireless devices for remote patient monitoring.).

Protecting America’s Tech Prowess Amid the Hostile Rhetoric of 2017

Xconomy

Along with that comes the responsibility of leadership in developing the consensus to make long term investments in research and education and manage them effectively. A lot of the technological innovation in the United States is done by recent immigrants who obtained their graduate degrees.

Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals

Xconomy

With the inauguration of Donald Trump as president on January 20th, the editors asked some of our Xconomists to offer their thoughts on “How could the incoming administration significantly affect your industry?” That being said, here’s what I’ll be keeping an eye on in Washington in 2017. Overall, the bill will. Food and Drug Administration

Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs

Xconomy

No longer. For now, he’s working with venture capitalist colleagues on some new companies that have yet to be officially launched.

At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy

Xconomy

Still, it’s important to keep these data in perspective. Immune reactions to gene therapy can also stifle its effects.

Water Metering Startup Wins Vote for “Best Demo” at EvoNexus Event

Xconomy

A San Diego civil engineer who has developed an alternative technology for automating the measurement of water flow gave the best presentation at EvoNexus Fall Demo Day, an event that drew nearly 400 entrepreneurs, investors, and supporters late Thursday to Qualcomm’s corporate headquarters. million and take five years, Sekeroglu said.

Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer

Xconomy

Speaking at a conference in San Francisco Wednesday, geneticist Craig Venter revealed that he had just had surgery for prostate cancer three weeks ago.

The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update

Xconomy

Xconomy reported last week on the new use of these cells to treat multiple myeloma. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

With New Program, DARPA To Encourage Safety “Brakes” For Gene Editing

Xconomy

Defense Advanced Research Projects Agency—a famed military R&D group—wants to finance safety measures for the new gene-editing age. “We should couple innovation with biosecurity,” DARPA program manager Renee Wegrzyn, said Tuesday at the SynBioBeta conference in South San Francisco. The U.S.

New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease

Xconomy

Evercore ISI analyst John Scotti wrote in a research note this morning that an estimated 2,500 patients in the U.S., points.

Study 27

Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing

Xconomy

Cure SMA helped fund the drug program in 2003 when it started out as research at the University of Massachusetts, before it was licensed to Ionis.

Study 29

The Five Major Tech Trends of 2016

Xconomy

To augment and overcome physical distance, we are starting to use drones, virtual reality, and driverless cars. percent of digital buyers in the U.S.

Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA

Xconomy

Cure SMA backed early research that helped scientists understand the underlying cause of SMA. Jessica sighs. Neither has ever walked.

Organovo to Test “Patches” for Patients Awaiting Liver Transplants

Xconomy

The idea is to help improve the function of failing livers, a stopgap measure that could extend the lives of patients on the U.S.

The Necessity of Innovation

Xconomy

Innovation is at the heart of wealth creation. Innovation is at the heart of job creation. And innovation can be increased by conscious support.

Why Teenagers Make Great Entrepreneurs

Xconomy

What is the ideal age to start a company? It’s a question that often circulates in the business press and on tech blogs. Wrong.

Riding Moonshot, FDA Will Revamp Its Cancer Practice. To What End?

Xconomy

But to what end? The goals of the FDA’s new Oncology Center of Excellence remain vague, as does its structure.

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. —South San Francisco-based Second Genome hired a new CEO and president. The week started on a reflective note. And perhaps most important, there was the U.S. Or not.

News 28

FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer

Xconomy

Roughly a quarter of all advanced NSCLC patients have cancer with high PD-L1 levels, according to earlier studies from Merck. months, compared to 6.0

Study 21

In Trump-GOP Tsunami, Blue-State Healthcare Ideas Swamped

Xconomy

The 2016 U.S. election is over. The country has been rocked by the presidential race, with Donald Trump taking the White House. It didn’t matter.

Ideas 19

As U.S. Looks to Launch Precision Health Study, Google’s Role Emerges

Xconomy

Google’s parent company Alphabet (NASDAQ: GOOG ) and its wholly owned biotech R&D group, Verily Life Sciences, are helping build a secure center where health records, genomic data, and other personal information from hundreds of thousands of people can be collected, analyzed, and shared with health researchers. The U.S.

Study 17

Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo

Xconomy

—Xconomy reported Monday that Tom Daniel, Celgene’s (NASDAQ: CELG ) former president of research and early development, left the Summit, NJ, company over the summer to start Catalysis Advisors in San Diego. The hikes were first reported earlier this month by Adam Feuerstein of The Street. You think that’s funny?

Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More

Xconomy

Elsewhere in Washington, the NIH chief warned about Congress’s inability to agree on Zika funding, and Vice President Joe Biden talked with Stat about cancer research. —Bill Gates, who has turned his own tech wealth into the world’s richest charitable foundation, was in San Francisco to cheer on Zuckerberg and Chan.

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

Xconomy

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. He helped turn a jellyfish protein into an invaluable lab tool that every researcher knows as “GFP”—green fluorescent protein, which is used to illuminate the inner workings of cells. He was a professor at UC San Diego.

Radicle Accelerator Fund Launches to Nurture AgTech Innovation

Xconomy

But Radicle’s plans more closely resemble the Research Triangle Park-based AgTech Accelerator, which shares an industry partner in Bayer.

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

Thousands of others will head to San Francisco for BIO, which has a distinct international flavor. BioMarin Pharmaceutical (NASDAQ: BMRN ) of San Rafael, CA, said it would not try to gain European approval of drisapersen , four months after U.S. billion acquisition of San Diego’s Auspex Pharmaceuticals last year.